Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Description

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.

Conditions

Arthritis, Rheumatoid

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Condition
Arthritis, Rheumatoid
Intervention / Treatment

-

Contacts and Locations

Ann Arbor

Universtity of Michigan Health System, Ann Arbor, Michigan, United States, 48109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men and women 18 years of age or older can participate in this study.
  • * Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study.
  • * Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis.
  • * Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  • * Pregnant patients.
  • * Patients who is claustrophobic.
  • * Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.
  • * Patients with shock hypotension or unstable low blood pressure.
  • * Patients with Rhabdomyolysis.
  • * Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Michigan,

Xueding Wang, Ph.D, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

2025-06